Product Code: ETC4471047 | Publication Date: Jul 2023 | Updated Date: Aug 2025 | Product Type: Report | |
Publisher: 6Wresearch | No. of Pages: 85 | No. of Figures: 45 | No. of Tables: 25 | |
The Malaysia apheresis market focuses on the collection and separation of specific blood components, such as platelets, plasma, and white blood cells, for therapeutic purposes. Apheresis procedures are crucial in treating various medical conditions, including autoimmune diseases and certain hematological disorders. The market has witnessed growth due to the increasing incidence of diseases that require apheresis, coupled with advancements in apheresis technology and equipment. It plays a vital role in maintaining the health and well-being of patients suffering from complex medical conditions.
The Malaysia apheresis market is primarily driven by the increasing incidence of various medical conditions that require apheresis procedures, such as autoimmune diseases and blood disorders. Apheresis is a crucial component of treatment for these conditions. Additionally, advancements in apheresis technology, improved reimbursement policies, and the rising demand for blood and plasma components further contribute to market growth.
Regulatory compliance and accreditation standards can present substantial challenges in the apheresis market. Meeting stringent requirements for safety, efficacy, and quality assurance may pose logistical and financial burdens for manufacturers and healthcare facilities alike. Additionally, ensuring a sufficient supply of skilled professionals proficient in apheresis techniques is crucial for the sustained growth of the market.
The COVID-19 pandemic posed both challenges and opportunities for the Malaysia apheresis market. Hospital resources were redirected towards managing COVID-19 cases, leading to a temporary decline in apheresis procedures for certain non-urgent indications. However, apheresis technology played a crucial role in the treatment of severe COVID-19 patients with complications like cytokine storms. This spotlight on apheresis as a life-saving intervention elevated awareness and stimulated advancements in technology. Consequently, the market is poised for growth as healthcare providers recognize the pivotal role of apheresis in critical care.
The apheresis market in Malaysia is experiencing notable expansion, driven by the rising demand for blood components and therapeutic plasma exchange procedures. Leading Players in this sector include Fresenius SE & Co. KGaA, Haemonetics Corporation, Terumo BCT, and Asahi Kasei Medical Co., Ltd. These companies have played pivotal roles in advancing apheresis technology and expanding its applications in various medical conditions. Their comprehensive product portfolios and extensive distribution networks have positioned them as leading contributors to the burgeoning Malaysia apheresis market.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Malaysia Apheresis Market Overview |
3.1 Malaysia Country Macro Economic Indicators |
3.2 Malaysia Apheresis Market Revenues & Volume, 2021 & 2031F |
3.3 Malaysia Apheresis Market - Industry Life Cycle |
3.4 Malaysia Apheresis Market - Porter's Five Forces |
3.5 Malaysia Apheresis Market Revenues & Volume Share, By Product, 2021 & 2031F |
3.6 Malaysia Apheresis Market Revenues & Volume Share, By Method, 2021 & 2031F |
3.7 Malaysia Apheresis Market Revenues & Volume Share, By Procedure, 2021 & 2031F |
3.8 Malaysia Apheresis Market Revenues & Volume Share, By Component, 2021 & 2031F |
3.9 Malaysia Apheresis Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 Malaysia Apheresis Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of chronic diseases in Malaysia |
4.2.2 Growing demand for blood components and plasma for therapeutic purposes |
4.2.3 Technological advancements in apheresis procedures |
4.3 Market Restraints |
4.3.1 High cost associated with apheresis procedures |
4.3.2 Limited awareness and accessibility to apheresis services in remote areas of Malaysia |
5 Malaysia Apheresis Market Trends |
6 Malaysia Apheresis Market, By Types |
6.1 Malaysia Apheresis Market, By Product |
6.1.1 Overview and Analysis |
6.1.2 Malaysia Apheresis Market Revenues & Volume, By Product, 2021-2031F |
6.1.3 Malaysia Apheresis Market Revenues & Volume, By Devices, 2021-2031F |
6.1.4 Malaysia Apheresis Market Revenues & Volume, By Disposable and Reagents, 2021-2031F |
6.1.5 Malaysia Apheresis Market Revenues & Volume, By Software, 2021-2031F |
6.2 Malaysia Apheresis Market, By Method |
6.2.1 Overview and Analysis |
6.2.2 Malaysia Apheresis Market Revenues & Volume, By Centrifugation, 2021-2031F |
6.2.3 Malaysia Apheresis Market Revenues & Volume, By Membrane Separation, 2021-2031F |
6.2.4 Malaysia Apheresis Market Revenues & Volume, By Selective Adsorption, 2021-2031F |
6.3 Malaysia Apheresis Market, By Procedure |
6.3.1 Overview and Analysis |
6.3.2 Malaysia Apheresis Market Revenues & Volume, By Donor/Automated Apheresis, 2021-2031F |
6.3.3 Malaysia Apheresis Market Revenues & Volume, By Therapeutic Apheresis, 2021-2031F |
6.4 Malaysia Apheresis Market, By Component |
6.4.1 Overview and Analysis |
6.4.2 Malaysia Apheresis Market Revenues & Volume, By Plasma (Plasmapheresis), 2021-2031F |
6.4.3 Malaysia Apheresis Market Revenues & Volume, By Platelets (Plateletpheresis), 2021-2031F |
6.4.4 Malaysia Apheresis Market Revenues & Volume, By Leukocytes (Leukapheresis or leukopheresis), 2021-2031F |
6.4.5 Malaysia Apheresis Market Revenues & Volume, By Lymphocytes (Lymphopheresis or lymphapheresis), 2021-2031F |
6.4.6 Malaysia Apheresis Market Revenues & Volume, By RBC's (Erythropheresis), 2021-2031F |
6.5 Malaysia Apheresis Market, By End User |
6.5.1 Overview and Analysis |
6.5.2 Malaysia Apheresis Market Revenues & Volume, By Blood Centers, 2021-2031F |
6.5.3 Malaysia Apheresis Market Revenues & Volume, By Hospitals, 2021-2031F |
6.5.4 Malaysia Apheresis Market Revenues & Volume, By Other End Users, 2021-2031F |
7 Malaysia Apheresis Market Import-Export Trade Statistics |
7.1 Malaysia Apheresis Market Export to Major Countries |
7.2 Malaysia Apheresis Market Imports from Major Countries |
8 Malaysia Apheresis Market Key Performance Indicators |
8.1 Average waiting time for apheresis procedures in healthcare facilities |
8.2 Number of accredited apheresis centers in Malaysia |
8.3 Adoption rate of new apheresis technologies and techniques |
9 Malaysia Apheresis Market - Opportunity Assessment |
9.1 Malaysia Apheresis Market Opportunity Assessment, By Product, 2021 & 2031F |
9.2 Malaysia Apheresis Market Opportunity Assessment, By Method, 2021 & 2031F |
9.3 Malaysia Apheresis Market Opportunity Assessment, By Procedure, 2021 & 2031F |
9.4 Malaysia Apheresis Market Opportunity Assessment, By Component, 2021 & 2031F |
9.5 Malaysia Apheresis Market Opportunity Assessment, By End User, 2021 & 2031F |
10 Malaysia Apheresis Market - Competitive Landscape |
10.1 Malaysia Apheresis Market Revenue Share, By Companies, 2024 |
10.2 Malaysia Apheresis Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |